21 February 2018 EMA/270645/2015 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: interferon alpha-2a

Procedure no.: PSUSA/00009197/201706

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 3 miljoen Internationale

NL/H/0028/011

BE207602

N.V. ROCHE S.A.

BE

NL/H/0028/011

BE207602

N.V. ROCHE S.A.

BE

NL/H/28/13

BE207627

N.V. ROCHE S.A.

BE

NL/H/28/13

BE207627

N.V. ROCHE S.A.

BE

NL/H/0028/014

BE207636

N.V. ROCHE S.A.

BE

NL/H/0028/014

BE207636

N.V. ROCHE S.A.

BE

NL/H/0028/011

16834

ROCHE OY

FI

NL/H/0028/011

16834

ROCHE OY

FI

NL/H/0028/013

16836

ROCHE OY

FI

NL/H/0028/013

16836

ROCHE OY

FI

NL/H/0028/014

16837

ROCHE OY

FI

Eenheden (IE) oplossing voor injectie in voorgevulde spuit Roferon-A 3 Millionen Internationale Einheiten (IE) Injektionslösung in Fertigspritze Roferon-A 6 miljoen Internationale Eenheden (IE) oplossing voor injectie in voorgevulde spuit Roferon-A 6 Millionen Internationale Einheiten (IE) Injektionslösung in Fertigspritze Roferon-A 9 miljoen Internationale Eenheden (IE) oplossing voor injectie in voorgevulde spuit Roferon-A 9 Millionen Internationale Einheiten (IE) Injektionslösung in Fertigspritze Roferon-A 3 milj. IU injektioneste, liuos, esitäytetyssä ruiskussa Roferon-A 3 milj. IU injektionsvätska, lösning, i förfylld spruta Roferon-A 6 milj. IU injektioneste, liuos, esitäytetyssä ruiskussa Roferon-A 6 milj. IU injektionsvätska, lösning, i förfylld spruta Roferon-A 9 milj. IU injektioneste, liuos, esitäytetyssä ruiskussa List of nationally authorised medicinal products EMA/201520/2018

Page 2/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

ROFERON®-A 9 milj. IU

NL/H/0028/014

16837

ROCHE OY

FI

NL/H/2008/11

2009030360

N.V. ROCHE S.A.

LU

NL/H/0028/013

2009030362

N.V. ROCHE S.A.

LU

NL/H/0028/014

2009030363

N.V. ROCHE S.A.

LU

NL/H/0028/013

2974483

ROCHE FARMACÊUTICA

PT

injektionsvätska, lösning, i förfylld spruta Roferon-A 3 Millionen Internationale Einheiten (IE) Injektionslösung in Fertigspritze Roferon-A 6 Millionen Internationale Einheiten (IE) Injektionslösung in Fertigspritze Roferon-A 9 Millionen Internationale Einheiten (IE) Injektionslösung in Fertigspritze Roferon-A 6 milhões de unidades internacionais (MUI) solução injectável

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 6 milhões de unidades

NL/H/0028/013

2974582

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 6 milhões de unidades

NL/H/0028/013

2974681

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 6 milhões de unidades

NL/H/0028/013

2974780

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 6 milhões de unidades

NL/H/0028/013

2974889

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 9 milhões de unidades internacionais (MUI) solução injectável

NL/H/0028/014

2975183

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia

List of nationally authorised medicinal products EMA/201520/2018

Page 3/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 9 milhões de unidades

NL/H/0028/014

2975282

ROCHE FARMACÊUTICA

PT

internacionais (MUI) solução injectável

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 9 milhões de unidades

NL/H/0028/014

2975381

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 9 milhões de unidades

NL/H/0028/014

2974988

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 9 milhões de unidades

NL/H/0028/014

2975084

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 3 εκατομμύρια διεθνείς μονάδες

NL/H/0028/011

44839/12/22.10.2013

ROCHE (HELLAS) SA

GR

NL/H/028/011

62361/12/22.10.2013

ROCHE (HELLAS) SA

GR

NL/H/0028/011

H/97/01370/001

ROCHE FARMACEVTSKA

SI

Roferon-A 3 millió NE oldatos injekció

NL/H/0028/011

OGYI-T-6145/10

Roferon-A 3 mio i.e./0,5 ml raztopina za

NL/H/0028/011

H/97/01370/017

(MIU) ενέσιμο διάλυμα σε προγεμισμένη σύριγγα Roferon-A 4,5 εκατομμύρια διεθνείς μονάδες (MIU) ενέσιμο διάλυμα σε προγεμισμένη σύριγγα Roferon-A 3 mio i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi

DRUŽBA D.O.O. ROCHE

HU

(MAGYARORSZÁG) KFT injiciranje v napolnjeni injekcijski brizgi Roferon-A 3 mio i.e./0,5 ml raztopina za

injiciranje v napolnjeni injekcijski brizgi

List of nationally authorised medicinal products EMA/201520/2018

SI

DRUŽBA D.O.O. NL/H/0028/011

H/97/01370/016

injiciranje v napolnjeni injekcijski brizgi Roferon-A 3 mio i.e./0,5 ml raztopina za

ROCHE FARMACEVTSKA ROCHE FARMACEVTSKA

SI

DRUŽBA D.O.O. NL/H/0028/011

H/97/01370/004

ROCHE FARMACEVTSKA

SI

DRUŽBA D.O.O.

Page 4/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 3 mio i.e./0,5 ml raztopina za

NL/H/0028/011

H/97/01370/005

ROCHE FARMACEVTSKA

SI

injiciranje v napolnjeni injekcijski brizgi Roferon-A 3 mio i.e./0,5 ml raztopina za

DRUŽBA D.O.O. NL/H/0028/011

H/97/01370/002

ROCHE FARMACEVTSKA

NL/H/0028/011

H/97/01370/003

ROCHE FARMACEVTSKA

NL/H/0028/011

1-23200

ROCHE AUSTRIA GMBH

AT

NL/H/0028/011

44/086/02-C

ROCHE S. R. O.

CZ

NL/H/0028/014

44/087/02-C

ROCHE S. R. O.

CZ

NL/H/0028/011

44/160/99-C

ROCHE S. R. O.

CZ

NL/H/0028/014

BE207636

N.V. ROCHE S.A.

BE

NL/H/0028/014

184697

ROCHE EESTI OÜ

EE

NL/H/0028/011

184897

ROCHE EESTI OÜ

EE

NL/H/0028/011

34009 352 578 9 5

ROCHE

FR

injiciranje v napolnjeni injekcijski brizgi Roferon-A 3 mio i.e./0,5 ml raztopina za

DRUŽBA D.O.O.

injiciranje v napolnjeni injekcijski brizgi Roferon-A „Roche“ 3 Mio I.E./0,5 ml –

SI SI

DRUŽBA D.O.O.

Injektionslösung in einer Fertigspritze Roferon-A 6 MIU/0,5 ml 6 milionů mezinárodních jednotek (IU) Injekční roztok v předplněné injekční stříkačce Roferon-A 9 MIU/0,5 ml 9 milionů mezinárodních jednotek (IU) Injekční roztok v předplněné injekční stříkačce Roferon-A 3 MIU/0,5 ml 3 miliony mezinárodních jednotek (IU) Injekční roztok v předplněné injekční stříkačce Roferon-A 9 millions d’unités internationales (UI) solution injectable en seringue pré-remplie Roferon-A, 9 miljonit rahvusvahelist ühikut (RÜ), süstelahus süstlis Roferon-A, 3 miljonit rahvusvahelist ühikut (RÜ), süstelahus süstlis Roferon-A 3 millions d'unités internationales (UI), solution injectable en seringue préremplie

List of nationally authorised medicinal products EMA/201520/2018

Page 5/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 3 millions d'unités

NL/H/0028/011

34009 352 573 7 6

ROCHE

FR

NL/H/0028/011

34009 352 577 2 7

ROCHE

FR

NL/H/0028/011

34009 352 574 3 7

ROCHE

FR

NL/H/0028/011

34009 352 576 6 6

ROCHE

FR

NL/H/0028/012

34009 352 559 4 5

ROCHE

FR

NL/H/0028/012

34009 352 558 8 4

ROCHE

FR

NL/H/0028/012

34009 352 560 2 7

ROCHE

FR

NL/H/0028/012

34009 352 557 1 6

ROCHE

FR

NL/H/0028/012

34009 352 561 9 5

ROCHE

FR

internationales (UI), solution injectable en seringue préremplie Roferon-A 3 millions d'unités internationales (UI), solution injectable en seringue préremplie Roferon-A 3 millions d'unités internationales (UI), solution injectable en seringue préremplie Roferon-A 3 millions d'unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 4,5 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 4,5 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 4,5 millions d’unités internationales (UI), solution injectable en seringue préremplie Roferon-A 4,5 millions d'unités internationales (MUI), solution injectable en seringue préremplie ROFERON-A 4,5 millions d’unités internationales (UI), solution injectable en seringue préremplie

List of nationally authorised medicinal products EMA/201520/2018

Page 6/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

ROFERON-A 6 millions d’unités

NL/H/0028/013

34009 352 566 0 7

ROCHE

FR

NL/H/028/013

34009 352 564 8 5

ROCHE

FR

NL/H/0028/013

34009 352 565 4 6

ROCHE

FR

NL/H/0028/013

34009 352 562 5 6

ROCHE

FR

NL/H/0028/013

34009 352 563 1 7

ROCHE

FR

NL/H/0028/014

34009 352 570 8 6

ROCHE

FR

NL/H/0028/014

34009 352 568 3 6

ROCHE

FR

NL/H/0028/014

34009 352 567 7 5

ROCHE

FR

NL/H/0028/014

34009 352 572 0 8

ROCHE

FR

internationales (UI), solution injectable en seringue préremplie ROFERON-A 6 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 6 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 6 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 6 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 9 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 9 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 9 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 9 millions d’unités internationales (UI), solution injectable en seringue préremplie

List of nationally authorised medicinal products EMA/201520/2018

Page 7/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

ROFERON-A 9 millions d’unités

NL/H/0028/014

34009 352 571 4 7

ROCHE

FR

NL/H/0028/012

RVG 24156

ROCHE NEDERLAND B.V.

NL

NL/H/0028/014

RVG 24158

ROCHE NEDERLAND B.V.

NL

NL/H/0028/013

RVG 24157

ROCHE NEDERLAND B.V.

NL

NL/H/0028/011

RVG 24155

ROCHE NEDERLAND B.V.

NL

NL/H/0028/011

44/0371/05-S

ROCHE SLOVENSKO

SK

internationales (UI), solution injectable en seringue préremplie Roferon-A EasyJect 4,5, 4.500.000 IE, oplossing voor injectie in voorgevulde spuit Roferon-A EasyJect 9, 9.000.000 IE, oplossing voor injectie in voorgevulde spuit Roferon-A EasyJect 6, 6.000.000 IE, oplossing voor injectie in voorgevulde spuit Roferon-A EasyJect 3, 3.000.000 IE, oplossing voor injectie in voorgevulde spuit Roferon-A 9 MIU / 0,5 ml injekcný roztok naplnený v injekcnej striekacke Roferon-A 3 MIU/0,5 ml

S.R.O. NL/H/0028/011

44/0368/05-S

injekčný roztok naplnený v injekčnej

ROCHE SLOVENSKO

SK

S.R.O.

striekačke Roferon®-A 4,5 Mio. I.E./0,5 ml

NL/H/0028/012

45541.01.00

ROCHE PHARMA AG

DE

NL/H/0028/014

45541.03.00

ROCHE PHARMA AG

DE

NL/H/0028/013

45541.02.00

ROCHE PHARMA AG

DE

NL/H/0028/011

45541.00.00

ROCHE PHARMA AG

DE

Fertigspritze mit Injektionslösung Roferon®-A 9 Mio. I.E./0,5 ml Fertigspritze mit Injektionslösung Roferon®-A 6 Mio. I.E./0,5 ml Fertigspritze mit Injektionslösung Roferon®-A 3 Mio. I.E./0,5 ml Fertigspritze mit Injektionslösung

List of nationally authorised medicinal products EMA/201520/2018

Page 8/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 3 millones de unidades

NL/H/0028/011

62.999

ROCHE FARMA, S.A.

ES

NL/H/0028/012

62.992

ROCHE FARMA, S.A.

ES

NL/H/0028/013

62.993

ROCHE FARMA, S.A.

ES

NL/H/0028/014

62.994

ROCHE FARMA, S.A.

ES

NL/H/0028/014

025839275

ROCHE S.P.A.

IT

NL/H/0028/011

025839123

ROCHE S.P.A.

IT

NL/H/0028/011

025839147

ROCHE S.P.A.

IT

NL/H/0028/014

025839299

ROCHE S.P.A.

IT

NL/H/0028/011

025839111

ROCHE S.P.A.

IT

internacionales (UI) solución inyectable en jeringa precargada Roferon-A 4,5 millones de unidades internacionales (UI) solución inyectable en jeringa precargada Roferon-A 6 millones de unidades internacionales (UI) solución inyectable en jeringa precargada Roferon-A 9 millones de unidades internacionales (UI) solución inyectable en jeringa precargada Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 3 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 3 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 3 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita

List of nationally authorised medicinal products EMA/201520/2018

Page 9/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 6 milioni di unità internazionali

NL/H/0028/013

025839212

ROCHE S.P.A.

IT

NL/H/0028/014

025839301

ROCHE S.P.A.

IT

NL/H/0028/013

025839248

ROCHE S.P.A.

IT

NL/H/0028/011

025839150

ROCHE S.P.A.

IT

NL/H/0028/013

025839224

ROCHE S.P.A.

IT

NL/H/0028/011

025839135

ROCHE S.P.A.

IT

NL/H/0028/013

025839236

ROCHE S.P.A.

IT

NL/H/0028/014

025839287

ROCHE S.P.A.

IT

NL/H/0028/014

025839263

ROCHE S.P.A.

IT

(UI) soluzione iniettabile in siringa preriempita Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 6 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 3 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 6 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 3 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 6 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita

List of nationally authorised medicinal products EMA/201520/2018

Page 10/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 6 milioni di unità internazionali

NL/H/0028/013

025839251

ROCHE S.P.A.

IT

NL/H/0028/011

PL00031/0485

ROCHE PRODUCTS LTD

UK

NL/H/0028/012

PL00031/0486

ROCHE PRODUCTS LTD

UK

NL/H/0028/014

PL00031/0488

ROCHE PRODUCTS LTD

UK

NL/H/0028/013

PL00031/0487

ROCHE PRODUCTS LTD

UK

NL/H/0028/011

3400930038208

ROCHE

FR

NL/H/0028/011

3400930038215

ROCHE

FR

NL/H/0028/012

3400930038222

ROCHE

FR

NL/H/0028/012

3400930038239

ROCHE

FR

(UI) soluzione iniettabile in siringa preriempita Roferon-A 3 million international units (IU) solution for injection in pre-filled syringe Roferon-A 4.5 million international units (IU) solution for injection in pre-filled syringe Roferon-A 9 million international units (IU) solution for injection in pre-filled syringe Roferon-A 6 million international units (IU) solution for injection in pre-filled syringe ROFERON-A 3 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 3 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 4,5 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 4,5 millions d’unités internationales (UI), solution injectable en seringue préremplie

List of nationally authorised medicinal products EMA/201520/2018

Page 11/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

ROFERON-A 6 millions d’unités

NL/H/0028/013

3400930038246

ROCHE

FR

NL/H/0028/013

3400930038253

ROCHE

FR

NL/H/0028/014

34009 300 382 7 7

ROCHE

FR

NL/H/0028/014

34009 300 382 8 4

ROCHE

FR

NL/H/0028/011

OGYI-T-6145/02

ROCHE

HU

internationales (UI), solution injectable en seringue préremplie ROFERON-A 6 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 9 millions d’unités internationales (UI), solution injectable en seringue préremplie ROFERON-A 9 millions d’unités internationales (UI), solution injectable en seringue préremplie Roferon-A 3 millió NE oldatos injekció

(MAGYARORSZÁG) KFT Roferon-A ROCHE 4,5 Mio I.E./0,5 ml -

NL/H/0028/012

1-23201

ROCHE AUSTRIA GMBH

AT

NL/H/0028/013

1-23202

ROCHE AUSTRIA GMBH

AT

NL/H/0028/0011

15444

ROCHE AB

SE

NL/H/0028/011

OGYI-T-6145/01

ROCHE

HU

Injektionslösung in einer Fertigspritze Roferon-A „Roche“ 6 Mio. I.E./0,5 ml – Injektionslösung in einer Fertigspritze Roferon-A 3 miljoner Internationella Enheter (IE), injektionsvätska, lösning i förfylld spruta Roferon-A 3 millió NE oldatos injekció

(MAGYARORSZÁG) KFT Roferon-A 3 millió NE oldatos injekció

NL/H/0028/011

OGYI-T-6145/03

ROCHE

Roferon-A 3 millions d’unités

NL/H/2008/11

2009030360

N.V. ROCHE S.A.

HU

(MAGYARORSZÁG) KFT LU

internationales (UI) solution injectable en seringue pré-remplie

List of nationally authorised medicinal products EMA/201520/2018

Page 12/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 3 millions d’unités

NL/H/0028/011

BE207602

N.V. ROCHE S.A.

BE

NL/H/0028/013

2009030362

N.V. ROCHE S.A.

LU

NL/H/0028/013

BE207627

N.V. ROCHE S.A.

BE

NL/H/0028/014

2009030363

N.V. ROCHE S.A.

LU

NL/H/0028/011

2973782

ROCHE FARMACÊUTICA

PT

internationales (UI) solution injectable en seringue pré-remplie Roferon-A 6 millions d’unités internationales (UI) solution injectable en seringue pré-remplie Roferon-A 6 millions d’unités internationales (UI) solution injectable en seringue pré-remplie Roferon-A 9 millions d’unités internationales (UI) solution injectable en seringue pré-remplie Roferon-A 3 milhões de unidades internacionais (MUI) solução injectável

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 3 milhões de unidades

NL/H/0028/011

2973881

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 3 milhões de unidades

NL/H/0028/011

2973584

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 3 milhões de unidades

NL/H/0028/011

2973683

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 3 milhões de unidades

NL/H/0028/011

2973485

internacionais (MUI) solução injectável

ROCHE FARMACÊUTICA

PT

QUÍMICA, LDA.

em seringa pré-cheia Roferon-A 3 miljoni starptautisko vienību

NL/H/0028/006

05-0211

ROCHE LATVIJA SIA

LV

(SV) šķīdums injekcijām pilnšļircē

List of nationally authorised medicinal products EMA/201520/2018

Page 13/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A 3 milioni di unità internazionali

NL/H/0028/011

025839364

ROCHE S.P.A.

IT

NL/H/0028/011

025839376

ROCHE S.P.A.

IT

NL/H/0028/013

025839388

ROCHE S.P.A.

IT

NL/H/0028/014

025839402

ROCHE S.P.A.

IT

NL/H/0028/013

025839390

ROCHE S.P.A.

IT

NL/H/0028/014

025839414

ROCHE S.P.A.

IT

NL/H/0028/011

20076

G.A. STAMATIS & CO

CY

(UI) soluzione iniettabile in siringa preriempita Roferon-A 3 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 6 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 6 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 9 milioni di unità internazionali (UI) soluzione iniettabile in siringa preriempita Roferon-A 3 εκατομμύρια διεθνείς μονάδες (MIU) ενέσιμο διάλυμα σε προγεμισμένη

LTD

σύριγγα Roferon-A 9 milioane UI/0,5 ml soluţie

not available

6286/2014/01

ROCHE ROMANIA SRL

RO

not available

20011284

ROCHE BULGARIA EOOD

BG

not available

4651

ROCHE POLSKA SP.O.O.

PL

injectabilă Роферон-А 3 милиона IU/0,5 ml инжекционен разтвор в предварително напълнена спринцовка Roferon-A, 3 mln j.m./0,5 ml, roztwór do wstrzykiwań

List of nationally authorised medicinal products EMA/201520/2018

Page 14/15

Product Name (in authorisation

MRP/DCP Authorisation

National Authorisation

MAH of product in the

Member State where

country)

number

Number

member state

product is authorised

Roferon-A, 6 mln j.m./0,5 ml, roztwór do

not available

4653

ROCHE POLSKA SP.O.O.

PL

not available

4654

ROCHE POLSKA SP.O.O.

PL

not available

96-1010

F. HOFFMANN-LA ROCHE

NO

not available

96-1012

wstrzykiwań Roferon-A, 9 mln j.m./0,5 ml, roztwór do wstrzykiwań Roceron 6 mill. IE/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte Roceron18 mill. IE/ml injeksjonsvæske,

AG

oppløsning i ferdigfylt sprøyte Roferon-A 3 milijuna internacionalnih

F. HOFFMANN-LA ROCHE

NO

AG not available

UP/I-530-09/13-02/236

ROCHE D.O.O.

HR

jedinica (IU) otopina za injekciju u napunjenoj štrcaljki

List of nationally authorised medicinal products EMA/201520/2018

Page 15/15

PSUSA/00009197/201706 - European Medicines Agency - Europa EU

Feb 21, 2018 - 34009 352 558 8 4. ROCHE. FR. ROFERON-A 4,5 millions d'unités internationales (UI), solution injectable en seringue préremplie. NL/H/0028/012. 34009 352 560 2 7. ROCHE. FR. Roferon-A 4,5 millions d'unités internationales (MUI), solution injectable en seringue préremplie. NL/H/0028/012. 34009 352 ...

164KB Sizes 0 Downloads 147 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...